Modified HPV E6-E7 fusion gene and coding protein thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 曾毅
- Publication Date
- 2008-01-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the fields of genetic engineering and tumor treatment. Specifically, the present invention relates to a codon-optimized HPV16E6E7 fusion gene and its encoded protein, as well as three potential carcinogenicity-eliminated fusion genes obtained by site-directed mutagenesis of the codon-optimized HPV16 E6E7 fusion gene and its encoded protein. coded protein. Background technique
[0002] Human papillomavirus (Human Papillomavires, HPV) is a kind of DNA virus with strict host range and tissue specificity. It mainly infects human skin or mucosal epithelial cells, causing benign and malignant lesions at the infection site. With the deepening of HPV research, it is found that about 80% of cervical cancers are related to four types of HPV infection, namely HPV16, 18, 31 and 45, and 50% of cervical cancers are related to HPV16 infection (MH Stoler . Int J Gynecol Patho, 2000, 19(1): 16-28). According to statistics, there are about 51...